Audiology assessment of participants in CAMPSIITE™, a phase I/II/III study of RGX-121 in neuronopathic MPS II
Nidal Boulos, Paulo Falabella, Patricia Roush(University of North Carolina at Chapel Hill), Dawn Phillips(ProterixBio (United States)), Ariana Pjetri, Laura Rosa Pisani(Regenxbio (United States))
Cited by 0
Related Papers
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|252
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta‐analysis of risk factors
|Epilepsia|2016|180
Neuroimaging and cognitive functions in temporal lobe epilepsy: A review of the literature
|Journal of the Neurological Sciences|2017|158
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|153